A61K 49 - Preparations for testing in vivo

Patents for A61K 49 - Preparations for testing in vivo (35,376)
10/2011
10/20/2011	US20110256062 Methods
10/20/2011	US20110256061 Binding agents to the Integrin Alpha-11 subunit, and uses thereof
10/20/2011	US20110256060 Monoclonal antibody and its use for the identification of the oncofetal isoform of fibronectin (b-fn) for diagnosis or therpay
10/20/2011	US20110256059 Nanoparticulate systems prepared from anionic polymers
10/20/2011	US20110256058 Novel Peptides and Uses Thereof
10/20/2011	CA2796010A1 Trail r2-specific multimeric scaffolds
10/20/2011	CA2795360A1 Tissue targeting
10/19/2011	EP2376125A1 Erythrocyte-based delivery system, method of preparation and uses thereof
10/19/2011	EP2376124A2 Smart contrast agents for mri imaging
10/19/2011	EP2098522B1 Compounds having affinity for amyloid
10/19/2011	EP1725268B1 X-ray contrast formulation comprising a mixture of iodinated monomer and dimer
10/19/2011	EP1687024B1 Carbohydrate antigen-nanoparticle conjugates and uses thereof as antimetastatic agents in treating cancer
10/19/2011	CN1993357B Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (mri) which contain a chelating moiety with polyhydroxylated substituents
10/19/2011	CN102223905A Method for the production of scaffolds for tissue engineering, comprising the use of an anchoring unit, and scaffold produced therewith
10/19/2011	CN102220288A Mouse-addapted enterovirus EV71 strain 573 and use thereof
10/19/2011	CN102218150A Novel liver-targeting nanometer Fe3O4MRI (Magnetic Resonance Imaging) contrast medium and preparation method
10/19/2011	CN102218149A Medical ultrasonic couplant capable of disinfection and sterilization and preparation technology thereof
10/19/2011	CN102218146A ShRNA (Short Hairpin Ribonucleic Acid) kit for treating animal model suffered from alzheimer disease
10/19/2011	CN101695476B Method for preparing medical nanoparticles
10/18/2011	US8038996 Composition and method for cancer treatment
10/18/2011	US8038986 Immunogenic compositions and diagnostic and therapeutic uses thereof
10/18/2011	US8038983 Fluorinated carbohydrate conjugates
10/18/2011	CA2515663C Chitosan-based transport system
10/18/2011	CA2494541C Shiga toxin b-subunit as a vector for tumor diagnosis and drug delivery to gb3 expressing tumors
10/18/2011	CA2469459C Methods and compositions for the diagnosis of asthma
10/18/2011	CA2449550C Imaging of biological structures
10/18/2011	CA2403218C Embolic compositions
10/13/2011	WO2011126010A1 Cancer cell-specific cell-penetrating peptide and use thereof
10/13/2011	WO2011124672A1 Process for preparing hyperpolarized substrates and method for mri
10/13/2011	WO2011059609A9 Dendrimer compositions and methods of synthesis
10/13/2011	US20110252486 Chondrocyte-like cell, and method for producing same
10/13/2011	US20110252485 Novel gene disruptions, compositions and methods relating thereto
10/13/2011	US20110250146 Magnetic nanoparticle and method for imaging t cells
10/13/2011	US20110250145 Bioluminescence imaging of myeloperoxidase activity in vivo, methods, compositions and apparatuses therefor
10/13/2011	US20110250144 Rgd-containing peptidomimetics and uses thereof
10/13/2011	US20110250143 Process for preparing chlorins and their pharmaceutical uses
10/13/2011	US20110250142 Combination therapies for treatment of hypertension and complications in patients with diabetes or metabolic syndrome
10/13/2011	US20110250141 Methods For Improving Skin Quality
10/13/2011	US20110250140 Modified Pyrazine Derivatives and Uses Thereof
10/13/2011	US20110250139 Modified Pyrazine Derivatives and Uses Thereof
10/13/2011	US20110250138 Single-stranded and double-stranded oligonucleotides comprising a metal-chelating ligand
10/13/2011	US20110250135 Piperazine Derivatives for Binding and Imaging Amyloid Plaques and Their Use
10/13/2011	US20110250131 Antigens Associated with Endometriosis, Psoriatic Arthritis and Psoriasis
10/13/2011	CA2795734A1 Tnf-.alpha. binding proteins
10/12/2011	EP2374893A2 Orthopic reconstituted human breast tumor in mouse
10/12/2011	EP2374484A2 Methods for embolizing blood vessels
10/12/2011	EP2374016A2 Pulse sequencing with hyperpolarisable nuclei
10/12/2011	EP2373597A2 Radioisotope-labeled lysine and ornithine derivatives, their use and processes for their preparation
10/12/2011	EP2373350A2 Encapsulating system for cest imaging with chelate q greater than or equal to 2
10/12/2011	EP2373349A1 Dye conjugate imaging agents
10/12/2011	CN1953770B X-ray visible drug delivery device
10/12/2011	CN1925878B Contrast agents for myocardial perfusion imaging
10/12/2011	CN102212116A Acetylcholine receptor mediated brain-targeted polypeptide and application thereof
10/12/2011	CN102212090A Water-soluble sugar phthalocyanine fluorescent compound, and preparation method and application thereof
10/12/2011	CN102211753A Composite material having multiple characteristics in surface and preparation method thereof
10/12/2011	CN102210754A Method for constructing monkey model with kidney deficiency AIDS (Acquired Immure Deficiency Syndrome) in traditional Chinese medicine and application of monkey model
10/12/2011	CN101732733B CT imaging contrast agent and preparation method thereof
10/11/2011	US8035376 Optical pumping modules, polarized gas blending and dispensing systems, and automated polarized gas distribution systems and related devices and methods
10/11/2011	US8033977 Methods of enhancing radiation effects with metal nanoparticles
10/11/2011	CA2402773C Tissue bulking and coating compositions
10/06/2011	WO2011123820A2 Novel rhodamine dyes and conjugates
10/06/2011	WO2011123030A1 Nanoparticles comprising a core of amorphous rare earth element hydroxide and an organic coating
10/06/2011	WO2011122947A1 Staining composition
10/06/2011	WO2011122770A2 Magnetic resonance imaging contrast agent coated with polymer having mannose-modified terminal, and preparation method thereof
10/06/2011	WO2011121002A1 Hydroxylated phosphorylated contrast enhancement agents
10/06/2011	WO2011035279A3 Nanocarriers for imaging and therapy applications
10/06/2011	WO2011031915A3 Azulene and azaazulene systems for imaging, monitoring and therapy
10/06/2011	WO2011020107A3 Compositions and methods for detection and treatment of breast cancer
10/06/2011	US20110243914 Shiga toxin b-subunit as a vector for tumor diagnosis and drug delivery to gb3 expressing tumors
10/06/2011	US20110243859 Encapsulating system for cest imaging with chelate q greater than or equal to 2
10/06/2011	US20110243858 Hydroxylated contrast enhancement agents and imaging method
10/06/2011	US20110243857 Smart contrast agents for mri imaging
10/06/2011	US20110243856 Permeable Mixtures, Methods and Compositions for the Skin
10/06/2011	US20110243855 Method and imaging medium for use in the method
10/06/2011	US20110243854 Methods and systems for identifying modulators of longevity
10/06/2011	US20110243853 Models of erythropoiesis
10/06/2011	US20110243852 Method for the production of labelled scaffolds, comprising at least one reactive fluorinated surfactant, and scaffold produced therewith
10/06/2011	US20110243851 Glucose-peg conjugates for reducing glucose transport into a cell
10/06/2011	US20110243850 Probe for a biological specimen and labelling method and screening method using the probe
10/06/2011	US20110243849 Heme-binding photoactive polypeptides and methods of use thereof
10/06/2011	US20110243848 Star polymers, methods of preparation thereof, and uses thereof
10/06/2011	US20110243847 Imaging diagnostics by combining contrast agents
10/06/2011	US20110243842 Mammalian receptor proteins; related reagents and methods
10/06/2011	US20110243840 Monoclonal antibodies against orthopoxviruses
10/06/2011	CA2830052A1 Injectable dendrimer hydrogel nanoparticles
10/06/2011	CA2795444A1 Staining composition
10/06/2011	CA2794678A1 Novel rhodamine dyes and conjugates
10/05/2011	EP2371925A1 A sensor material, and uses thereof to simultaneously sense two analytes
10/05/2011	EP2371861A1 Monoclonal antibodies against extracellular loops of C5aR
10/05/2011	EP2371396A1 Truncated fragments of alpha synuclein in lewy body disease
10/05/2011	EP2371395A1 Staining Composition
10/05/2011	EP2370111A1 Probe for a biological specimen and labelling method and screening method using the probe
10/05/2011	EP2370110A1 Labeling composition for intraocular tissue, labeling method of intraocular tissue, and screening method
10/05/2011	EP2370106A2 Active ingredient-peptide construct for extracellular enrichment
10/05/2011	EP2370105A2 Transport-mediating colloidal pharmaceutical compounds
10/05/2011	EP2370058A1 Liposomal composition for convection-enhanced delivery to the central nervous centre
10/05/2011	EP1920786B1 Oral preparation for measuring pyrimidine metabolic capacity
10/05/2011	EP1784227B1 Mr imaging method for the discrimination between healthy and tumour tissue
10/05/2011	EP1757186B1 Restless legs syndrome/periodic appendicular dyskinesia model animal
10/05/2011	EP1713935B1 Modulation of hsv infection

1 ... 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 ... 354